Abstract
Different population groups of French Polynesia, Cook Islands and Fiji were screened for Human T-Lymphotropic Virus type I (HTLV-I) antibodies. Among 1487 individuals sampled in French Polynesia, twelve were considered Western Blot (WB) indeterminate and one was considered WB-positive for HTLV-I infection. This positive subject originated from France and was a blood donor. Out of 196 Polynesians of the Cook Islands, one was WB-indeterminate. Among populations sampled in Fiji, one of 222 Melanesians was found WB-indeterminate and one of 211 Indians was WB-indeterminate.
This is a preview of subscription content, log in via an institution to check access.
References
AsherD.M., GoudsmitJ., PomeroyK.L., et al. (1988): Antibodies to HTLV-I in populations of the southwestern Pacific - J. Med. Virol. 26: 339–351.
BrindleR.J., EglinR.P., ParsonsA.J., HillA.V.S. and SelkonJ.B. (1988): HTLV-1, HIV-1, hepatitis B and hepatitis delta in the Pacific and South-East Asia: a serological survey - Epidem. Inf. 100: 153–156.
Centers for Disease Control (1988): Licensure of screening tests for antibody to human T-lymphotropic virus type I - MMWR 37: 736–747.
ChungueE., BurucoaC., CartelJ.L., RouxJ. and GrasC. (1989): Serological survey of human T-cell leukemia virus type I in homosexual men in Tahiti -Med. J. Aust. 150: 349.
GarrutoR.M., SloverP., MoraC., et al. (1990): High prevalence rates of human T-lymphotropic virus type I (HTLV-I) infection in isolated populations of the western Pacific region confirmed by western immunoblot - Am. J. Hum. Biol. 2: 439–447.
GessainA., BarinF. and VernantL.C.(1985): Antibodies to human T-lymphotropic virus type I in patients with tropical spastic paraparesis - Lancet ii: 698.
GessainA., YanagiharaR., FranchiniG., et al. (1991): Highly divergent molecular variants of human T-lymphotropic virus type I from isolated populations in Papua New Guinea and the Solomon Islands -Proc. Nat. Acad. Sci. USA 88: 7694–7698.
HinumaY., NagataK., HanaoakaM., et al. (1981): Adult T-cell leukemia: Antigens in an ATL cell line and detection of antibodies to the antigen in human sera - Proc. Nat. Acad. Sci. USA 19: 6476–6480.
HinumaY., KomodaH., ChosaT., et al. (1982): Antibodies to adult T-cell leukemia virus associated antigen (ATL) in sera from patients with ATL and controls in Japan: A nationwide seroepidemiologic study - Int J. Cancer 29: 631–635.
LevineP.H., BlattnerW.A., ClarkJ., et al. (1988): Geographic distribution of HTLV-I and identification of a new high-risk population - Int. J. Cancer 42: 7–12.
MayJ.T., StentG., BishopR. and SchnaglD. (1990): Prevalence of antibody to human T-lymphotropic virus type-1 (HTLV-I) in Australian aborigenes and detection in Indonesian sera - Acta virol. 34: 80–84.
NicholsonS.R., EfandisT., DimitrakisM., KaropoulosA., LeeH. and GustL.D. (1992): HTLV-I infection in selected populations in Australia and the western Pacific - Med. J. Aust. 156: 878–880.
PoieszP.J., RuscettiF.W., ReitzM.,et al. (1980): Detection and isolation of type-C retroviruses particles from fresh and cultured lymphocytes of a patient with cutaneous lymphoma - Proc Nat Acad Sci USA 77: 7415–7419.
Rodgers-JohnsonP., GajdusekD.C. and MorganO.C. (1985): HTLV-I and HTLV-II antibodies and tropical spastic paraparesis - Lancet ii: 1247–1248.
SaksenaN.K., ShermanM.P., YanagiharaR., DubeD.K. and PoiezB.J. (1992): LTR sequence and phylogenetic analyses of a newly discovered variant of HTLV-I isolated from the Hagahai of Papua New Guinea - Virology 189: 1–9.
ShermanM.P., SaksenaN.R., DubeD.K., YanagiharaR. and PoiezB.J. (1992): Evolutionary insights on the origin of Human T-Cell Lymphoma/Leukemia Virus Type I (HTLV-I) derived from sequence analysis of a new HTLV-I variant from Papua New Guinea - J. Virol. 66: 2556–2563.
SpiegelA., CartelJ.L., ChungueE., et al. (1991): HTLV-I in French Polynesia: a serological survey in sexually exposed groups - Med. J. Aust. 155: 718.
Suzuki H. (1988): Prevalence rates of HTLV-I infection in the Asia-Pacific countries. In: World Health Organization, Manila, eds. Training course on the laboratory diagnosis of human immunodeficiency virus, human T lymphotropic virus type I and hepatitis B virus infections, in the South Pacific, Nuku'alofa, Tonga, November 2–6, 1987. pp. 15–16.
VerdierM., DenisF., SangareA., et al. (1990): Antibodies to T Lymphotropic Virus Type 1 in patients with Leprosy in Tropical Areas - J. Infect. Dis. 161: 1309–1310.
WhiktorS.Z., AlexanderS.S., ShawG.M., WeissS.H., MurphyE.L., WilksR.J., ShortlyV.J., HanchardB. and BlattnerW.A. (1990): Distinguishing between HTLV-I and HTLV-II by western blot - Lancet 335: 1533.
YanagiharaR., AjdukiewiczA.B., GarrutoR.M., et al. (1991): Human T-lymphotropic virus type I infection in the Solomon Islands - Am. J. Trop. Med. Hyg. 44: 122–130.
YanagiharaR., NerurkarV.R. and AjdukiewiczA.B. (1991): Comparison between strains of HTLV-I isolated from inhabitants of the Solomon Islands and Papua New Guinea - J. Infect. Dis. 164: 443–449.
YanagiharaR., NerurkarV.R., GarrutoR.M., et al. (1991): Characterization of a variant of human T-lymphotropic virus type-I isolated from a healthy member of a remote, recently contacted group in Papua New Guinea - Proc. Nat. Acad. Sci. USA 88: 1446–1450.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chungue, E., Boutin, J.P., Le Marchand, L. et al. Seroepidemiological survey of HTLV-I infection in French Polynesia, Cook Islands and Fiji. Eur J Epidemiol 9, 347–350 (1993). https://doi.org/10.1007/BF00146276
Issue Date:
DOI: https://doi.org/10.1007/BF00146276